Register to get unlimited access to our investor forum and all editorial content, including our e-zine and weekly email. Registration is free and only takes a minute.

Comment & Analysis

Ian Cowie: patient capital review great news for trusts

The penny has dropped at the Treasury with the chancellor’s announcement that listed venture capital funds are a good way to finance new, growth companies.

My investment trust winners and losers from 2016/17

Peter Hewitt, investment trust picker for F&C Managed Portfolio, reveals the closed end funds that stood out in a turbulent but positive year.

ESO: the private equity fund lighting up an overlooked sector

Matthew Read of Marten & Co assesses the post-crisis record of EPE Special Opportunities.

John Spiers: what put us off popular PRS Reit

PRS real estate investment trust raised an impressive £250 million in May. EQ Investors' founder explains why wealth manager did not get involved.

Trust Tips: Winterflood prunes New Year recommendations

Winterflood Securities takes profits and makes some big calls on its investment trust recommendations in anticipation of a rougher time for stock markets.

Trust Tips: Numis' nine changes for cautious markets

Half-year review of investment trust recommendations sees Numis Securities' change two equity funds and seven in pricey 'alternative assets'.

Dividends and biotech: a blockbuster combination?

Anyone in doubt about the revitalising effect dividends can have on an investment trust’s share price need only look at International Biotechnology Trust.

James Carthew: a Reit long and winding road

A look at LXI real estate investment trust and the small band of real estate investment trusts focused on properties let on long leases.

Investment Trust Watch: tender frenzy shakes up shares

Shares in Invesco Asia are looking expensive after its board spent £39.2 million buying back a big chunk of them this morning.

James Carthew: the relentless rise of new income funds

Investors continue to pour money into new property, infrastructure and specialist equity investment companies.